World Asset Management’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | $305K | Sell |
3,178
-133
| -4% | -$12.8K | 0.03% | 612 |
|
|
2021
Q2 | $322K | Sell |
3,311
-127
| -4% | -$12.4K | 0.03% | 634 |
|
|
2021
Q1 | $325K | Buy |
+3,438
| New | +$325K | 0.03% | 649 |
|
|
2020
Q3 | – | Sell |
-1,656
| Closed | -$202K | – | 801 |
|
|
2020
Q2 | $202K | Buy |
+1,656
| New | +$202K | 0.02% | 706 |
|
|
2020
Q1 | – | Sell |
-2,610
| Closed | -$281K | – | 1015 |
|
|
2019
Q4 | $281K | Sell |
2,610
-396
| -13% | -$42.6K | 0.01% | 830 |
|
|
2019
Q3 | $271K | Buy |
3,006
+39
| +1% | +$3.52K | 0.01% | 880 |
|
|
2019
Q2 | $251K | Sell |
2,967
-22
| -0.7% | -$1.86K | 0.01% | 942 |
|
|
2019
Q1 | $263K | Sell |
2,989
-49
| -2% | -$4.31K | 0.01% | 906 |
|
|
2018
Q4 | $217K | Sell |
3,038
-156
| -5% | -$11.1K | 0.01% | 908 |
|
|
2018
Q3 | $393K | Buy |
3,194
+40
| +1% | +$4.92K | 0.02% | 809 |
|
|
2018
Q2 | $310K | Sell |
3,154
-80
| -2% | -$7.86K | 0.02% | 931 |
|
|
2018
Q1 | $268K | Sell |
3,234
-728
| -18% | -$60.3K | 0.01% | 1055 |
|
|
2017
Q4 | $307K | Sell |
3,962
-60
| -1% | -$4.65K | 0.01% | 1124 |
|
|
2017
Q3 | $246K | Buy |
+4,022
| New | +$246K | 0.01% | 1253 |
|